| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |